Log in
Enquire now

List of Translate Bio patents

List of Translate Bio patents
List of RadarFind patents
List of L-3 Communications (company) patents
List of TigerConnect patents
List of funding rounds for Twistlock
Companies in the File sharing industry
Patents where
Current Assignee
Name
is
Translate BioTranslate Bio
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 10507183 Cleavable lipids

Patent 10507183 was granted and assigned to Translate Bio on December, 2019 by the United States Patent and Trademark Office.

Translate Bio
Translate Bio
Translate Bio
Translate Bio
United States Patent and Trademark Office
United States Patent and Trademark Office
10507183
December 17, 2019
‌
US Patent 10208295 MRNA therapy for phenylketonuria

Patent 10208295 was granted and assigned to Translate Bio on February, 2019 by the United States Patent and Trademark Office.

Translate Bio
Translate Bio
United States Patent and Trademark Office
United States Patent and Trademark Office
10208295
February 19, 2019
‌
US Patent 11547764 Lipid nanoparticle compositions and methods for MRNA delivery

Patent 11547764 was granted and assigned to Translate Bio on January, 2023 by the United States Patent and Trademark Office.

Translate Bio
Translate Bio
Translate Bio
Translate Bio
United States Patent and Trademark Office
United States Patent and Trademark Office
11547764
January 10, 2023
‌
US Patent 10155785 Methods for purification of messenger RNA

Patent 10155785 was granted and assigned to Translate Bio on December, 2018 by the United States Patent and Trademark Office.

Translate Bio
Translate Bio
United States Patent and Trademark Office
United States Patent and Trademark Office
10155785
December 18, 2018
‌
US Patent 10022455 Biodegradable lipids for delivery of nucleic acids

Patent 10022455 was granted and assigned to Translate Bio on July, 2018 by the United States Patent and Trademark Office.

Translate Bio
Translate Bio
Translate Bio
Translate Bio
United States Patent and Trademark Office
United States Patent and Trademark Office
10022455
July 17, 2018
‌
US Patent 11059841 Methods for purification of messenger RNA

Patent 11059841 was granted and assigned to Translate Bio on July, 2021 by the United States Patent and Trademark Office.

Translate Bio
Translate Bio
Translate Bio
Translate Bio
United States Patent and Trademark Office
United States Patent and Trademark Office
11059841
July 13, 2021
‌
US Patent 10137086 Lipid-derived neutral nanoparticles

Patent 10137086 was granted and assigned to Translate Bio on November, 2018 by the United States Patent and Trademark Office.

Translate Bio
Translate Bio
Translate Bio
Translate Bio
United States Patent and Trademark Office
United States Patent and Trademark Office
10137086
November 27, 2018
‌
US Patent 11224642 MRNA therapy for argininosuccinate synthetase deficiency

Patent 11224642 was granted and assigned to Translate Bio on January, 2022 by the United States Patent and Trademark Office.

Translate Bio
Translate Bio
United States Patent and Trademark Office
United States Patent and Trademark Office
11224642
January 18, 2022
‌
US Patent 10130649 Synergistic enhancement of the delivery of nucleic acids via blended formulations

Patent 10130649 was granted and assigned to Translate Bio on November, 2018 by the United States Patent and Trademark Office.

Translate Bio
Translate Bio
United States Patent and Trademark Office
United States Patent and Trademark Office
10130649
November 20, 2018
‌
US Patent 11377642 mRNA therapy for phenylketonuria

Patent 11377642 was granted and assigned to Translate Bio on July, 2022 by the United States Patent and Trademark Office.

Translate Bio
Translate Bio
Translate Bio
Translate Bio
United States Patent and Trademark Office
United States Patent and Trademark Office
11377642
July 5, 2022
‌
US Patent 10137087 Lipid-derived neutral nanoparticles

Patent 10137087 was granted and assigned to Translate Bio on November, 2018 by the United States Patent and Trademark Office.

Translate Bio
Translate Bio
Translate Bio
Translate Bio
United States Patent and Trademark Office
United States Patent and Trademark Office
10137087
November 27, 2018
‌
US Patent 10143758 Liver specific delivery of messenger RNA

Patent 10143758 was granted and assigned to Translate Bio on December, 2018 by the United States Patent and Trademark Office.

Translate Bio
Translate Bio
United States Patent and Trademark Office
United States Patent and Trademark Office
10143758
December 4, 2018
‌
US Patent 11104934 Quantitative assessment for cap efficiency of messenger RNA

Patent 11104934 was granted and assigned to Translate Bio on August, 2021 by the United States Patent and Trademark Office.

Translate Bio
Translate Bio
Translate Bio
Translate Bio
United States Patent and Trademark Office
United States Patent and Trademark Office
11104934
August 31, 2021
‌
US Patent 10413618 Lipid nanoparticle compositions and methods for mRNA delivery

Patent 10413618 was granted and assigned to Translate Bio on September, 2019 by the United States Patent and Trademark Office.

Translate Bio
Translate Bio
Translate Bio
Translate Bio
United States Patent and Trademark Office
United States Patent and Trademark Office
10413618
September 17, 2019
‌
US Patent 10238754 Lipid nanoparticle compositions and methods for MRNA delivery

Patent 10238754 was granted and assigned to Translate Bio on March, 2019 by the United States Patent and Trademark Office.

Translate Bio
Translate Bio
United States Patent and Trademark Office
United States Patent and Trademark Office
10238754
March 26, 2019
‌
US Patent 10350303 Lipid nanoparticle compositions and methods for mRNA delivery

Patent 10350303 was granted and assigned to Translate Bio on July, 2019 by the United States Patent and Trademark Office.

Translate Bio
Translate Bio
Translate Bio
Translate Bio
United States Patent and Trademark Office
United States Patent and Trademark Office
10350303
July 16, 2019
‌
US Patent 11234936 Cleavable lipids

Patent 11234936 was granted and assigned to Translate Bio on February, 2022 by the United States Patent and Trademark Office.

Translate Bio
Translate Bio
Translate Bio
Translate Bio
United States Patent and Trademark Office
United States Patent and Trademark Office
11234936
February 1, 2022
‌
US Patent 10172924 MRNA therapy for pompe disease

Patent 10172924 was granted and assigned to Translate Bio on January, 2019 by the United States Patent and Trademark Office.

Translate Bio
Translate Bio
United States Patent and Trademark Office
United States Patent and Trademark Office
10172924
January 8, 2019
‌
US Patent 11497716 Lipid-derived neutral nanoparticles

Patent 11497716 was granted and assigned to Translate Bio on November, 2022 by the United States Patent and Trademark Office.

Translate Bio
Translate Bio
Translate Bio
Translate Bio
United States Patent and Trademark Office
United States Patent and Trademark Office
11497716
November 15, 2022
‌
US Patent 11291734 Lipid nanoparticle compositions and methods for mRNA delivery

Patent 11291734 was granted and assigned to Translate Bio on April, 2022 by the United States Patent and Trademark Office.

Translate Bio
Translate Bio
Translate Bio
Translate Bio
United States Patent and Trademark Office
United States Patent and Trademark Office
11291734
April 5, 2022
‌
US Patent 10052284 Lipid formulations for delivery of messenger RNA

Patent 10052284 was granted and assigned to Translate Bio on August, 2018 by the United States Patent and Trademark Office.

Translate Bio
Translate Bio
United States Patent and Trademark Office
United States Patent and Trademark Office
10052284
August 21, 2018
‌
US Patent 11052159 Lipid nanoparticle compositions and methods for mRNA delivery

Patent 11052159 was granted and assigned to Translate Bio on July, 2021 by the United States Patent and Trademark Office.

Translate Bio
Translate Bio
Translate Bio
Translate Bio
United States Patent and Trademark Office
United States Patent and Trademark Office
11052159
July 6, 2021
‌
US Patent 10888626 Lipid nanoparticle compositions and methods for mRNA delivery

Patent 10888626 was granted and assigned to Translate Bio on January, 2021 by the United States Patent and Trademark Office.

Translate Bio
Translate Bio
Translate Bio
Translate Bio
United States Patent and Trademark Office
United States Patent and Trademark Office
10888626
January 12, 2021
‌
US Patent 10065919 Ionizable cationic lipids

Patent 10065919 was granted and assigned to Translate Bio on September, 2018 by the United States Patent and Trademark Office.

Translate Bio
Translate Bio
Translate Bio
Translate Bio
United States Patent and Trademark Office
United States Patent and Trademark Office
10065919
September 4, 2018
‌
US Patent 10087247 Methods and compositions for delivering mRNA coded antibodies

Patent 10087247 was granted and assigned to Translate Bio on October, 2018 by the United States Patent and Trademark Office.

Translate Bio
Translate Bio
United States Patent and Trademark Office
United States Patent and Trademark Office
10087247
October 2, 2018
Results per page:
99 results
0 selected
99 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us